Provided by Tiger Trade Technology Pte. Ltd.

Global Partners LP

48.06
-0.1300-0.27%
Post-market: 48.060.00000.00%18:09 EST
Volume:45.93K
Turnover:2.20M
Market Cap:1.63B
PE:23.10
High:48.64
Open:48.20
Low:47.35
Close:48.19
52wk High:59.20
52wk Low:39.58
Shares:34.00M
Float Shares:27.67M
Volume Ratio:1.05
T/O Rate:0.17%
Dividend:2.99
Dividend Rate:6.22%
EPS(TTM):2.08
EPS(LYR):2.41
ROE:13.77%
ROA:3.98%
PB:2.69
PE(LYR):19.94

Loading ...

Embracing Challenges for the Right Cause: WUXI APPTEC (02359) Supports 24 GLP-1 Drugs to Meet Urgent Clinical Needs

Stock News
·
Jan 15

Restaurant Industry Has Mixed Views on GLP-1 Drugs -- Market Talk

Dow Jones
·
Jan 15

GLP-1 Drugs Could Impact Restaurant Demand in 2026 -- Market Talk

Dow Jones
·
Jan 15

Why GLP-1 Weight-Loss Pills Might Be Great News for Airlines

TIPRANKS
·
Jan 15

Angela Zhao Named CEO of GLP China

prnewswire
·
Jan 14

Lexaria Deepens GLP-1 Focus With DehydraTECH Advances, Patents and Fresh Capital

TIPRANKS
·
Jan 13

Global Partners LP announces quarterly cash distribution of $0.59375 per Series B preferred unit

Reuters
·
Jan 12

Chipotle's High-Protein Push Targets GLP-1 Users, Analysts See Upside

Benzinga_recent_news
·
Jan 10

Toyota Hosts WORLD ARIGATO FEST.2025 to Thank Global Partners

Reuters
·
Jan 09

Omada announces results from 12-month analysis of GLP-1 companion program

TIPRANKS
·
Jan 08

Will Viking Therapeutics’ New CCO Reframe VKTX’s Obesity Strategy Amid Intensifying GLP-1 Competition?

Simply Wall St.
·
Jan 08

From Stressed Shoppers to GLP-1s, Albertsons CEO Says Supermarkets Face Tough Year -- WSJ

Dow Jones
·
Jan 08

GLP-1 Spillover, AI Empowerment... Could Biopharma Be the "Alternative" to Tech Stocks in 2026?

Deep News
·
Jan 07

Global Partners LP Files Initial Beneficial Ownership Statement for Chief Legal Officer Kristin K. Seabrook

Reuters
·
Jan 07

Global Partners LP Announces New Compensation Agreement for Senior Legal Advisor Sean T. Geary

Reuters
·
Jan 07

Vivo Bio Tech Secures Compliance Certificate for Regulatory Studies

MT Newswires Live
·
Jan 06

Fractyl Health Enters a Catalyst-Rich 2026 Positioned to Define the Post-GLP-1 Weight Maintenance Therapeutic Category

GlobeNewswire
·
Jan 05

Ascletis Announces U.S. FDA IND Clearance for 13-Week Phase II Study of Its Oral Small Molecule GLP-1, ASC30, in Participants with Diabetes

prnewswire
·
Jan 05

Multiple GLP-1 Weight Loss Drugs Set for 2026 Launch, Consumer Habits Poised for Major Shift

Deep News
·
Jan 02

CSPC PHARMA (01093): GLP-1/GIP Receptor Dual-Biased Agonist Polypeptide Injection (SYH2069 Injection) Receives Clinical Trial Approval in China

Stock News
·
Dec 29, 2025